Fosinopril Sodium

Fosinopril Sodium, an angiotensin-converting enzyme (ACE) inhibitor, has been the subject of several clinical trials investigating its effects on cardiovascular and renal health. These studies aim to evaluate its efficacy in treating conditions such as hypertension, chronic kidney disease, and microalbuminuria, as well as its potential to prevent cardiovascular events in high-risk individuals. The trials also explore the drug’s bioequivalence and its combination with other medications like hydrochlorothiazide and benidipine.

Table of Contents

What is Fosinopril?

Fosinopril sodium, also known by its brand name Monopril, is a medication that belongs to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors[1]. ACE inhibitors are commonly used to treat various cardiovascular and kidney-related conditions. Fosinopril works by helping to relax blood vessels, which can lower blood pressure and reduce the workload on the heart[2].

Conditions Treated by Fosinopril

Fosinopril is prescribed to treat several medical conditions, including:

  • Hypertension (High Blood Pressure): Fosinopril is effective in lowering blood pressure in patients with hypertension[1].
  • Chronic Kidney Disease (CKD): It is used to help protect kidney function in patients with CKD[1].
  • Heart Failure: Fosinopril can improve heart function in patients with heart failure[2].
  • Cardiovascular Disease Prevention: It may help prevent cardiovascular events in high-risk individuals[2].

How Fosinopril Works

Fosinopril works by inhibiting the angiotensin-converting enzyme (ACE) in the body. This enzyme is responsible for producing a substance called angiotensin II, which causes blood vessels to narrow. By blocking this enzyme, fosinopril helps to:

  • Relax and widen blood vessels
  • Lower blood pressure
  • Reduce the workload on the heart
  • Improve blood flow throughout the body

These effects can lead to better heart and kidney function, as well as a reduced risk of cardiovascular events[2].

Dosage and Administration

Fosinopril is typically taken orally in tablet form. The dosage can vary depending on the condition being treated and the individual patient’s needs. Some common dosages observed in clinical trials include:

  • 10 mg once daily for hypertension[3]
  • 20 mg once daily for cardiovascular disease prevention[4]

It’s important to note that dosages should always be determined by a healthcare professional based on your specific condition and medical history.

Combination Treatments

Fosinopril is sometimes prescribed in combination with other medications to enhance its effectiveness or treat multiple conditions simultaneously. Some common combinations include:

  • Fosinopril with Hydrochlorothiazide: This combination helps treat hypertension by combining the ACE inhibitor effects of fosinopril with the diuretic effects of hydrochlorothiazide[5].
  • Fosinopril with Benidipine: This combination has been studied for its effects on kidney function in patients with chronic kidney disease and hypertension[1].

Clinical Studies and Research

Fosinopril has been the subject of numerous clinical studies to evaluate its effectiveness and safety. Some notable research includes:

  • PREVEND IT Study: This study investigated the use of fosinopril and pravastatin in preventing cardiovascular and renal events in individuals with microalbuminuria (small amounts of protein in the urine)[4].
  • ACE Inhibition and Novel Cardiovascular Risk Factors Study: This research examined the effects of fosinopril on various blood markers associated with cardiovascular risk[2].
  • COPD and Muscle Weakness Study: A study investigating the potential benefits of fosinopril on muscle strength in patients with chronic obstructive pulmonary disease (COPD)[6].

Potential Side Effects

Like all medications, fosinopril can cause side effects in some patients. Common side effects may include:

  • Dizziness
  • Headache
  • Fatigue
  • Dry cough

More serious side effects, though rare, can include allergic reactions, changes in kidney function, or a sudden drop in blood pressure. It’s important to discuss any concerns or unusual symptoms with your healthcare provider[4].

Aspect Details
Main Uses in Trials Hypertension, Chronic Kidney Disease, Cardiovascular Disease Prevention, Microalbuminuria
Dosage Forms Tablets (various strengths, including 20mg, 40mg)
Combination Therapies With hydrochlorothiazide, benidipine, pravastatin
Key Outcomes Measured Blood pressure, kidney function (eGFR), proteinuria, cardiovascular events
Study Designs Randomized controlled trials, bioequivalence studies, crossover studies
Population Studied Adults with hypertension, CKD, or at high risk for cardiovascular disease; healthy volunteers for bioequivalence studies
Duration of Studies Ranging from single-dose studies to long-term trials (up to 4-5 years)

Ongoing Clinical Trials on Fosinopril Sodium

  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Austria Spain
  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    2 1 1
    Bulgaria Czechia Denmark France Germany Hungary +5

Glossary

  • Angiotensin-converting enzyme (ACE) inhibitor: A type of medication that helps relax blood vessels by blocking a substance that causes them to tighten. This can lower blood pressure and improve blood flow.
  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration to be pharmaceutically equivalent and to have the same effect in the body.
  • Chronic Kidney Disease (CKD): A condition characterized by gradual loss of kidney function over time, which can lead to complications in other organs.
  • Microalbuminuria: The presence of small amounts of albumin (a protein) in the urine, which can be an early sign of kidney damage.
  • Hypertension: High blood pressure, a condition where the force of blood against artery walls is consistently too high.
  • Cardiovascular disease: A group of disorders affecting the heart and blood vessels, including conditions like heart disease and stroke.
  • Glomerular filtration rate (eGFR): A measure of how well the kidneys are filtering waste from the blood, used to assess kidney function.
  • Proteinuria: The presence of excess proteins in the urine, which can be a sign of kidney damage.
  • Randomized controlled trial: A type of scientific experiment where participants are randomly assigned to different treatment groups to compare the effects of interventions.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the active drug or treatment being studied.

References

  1. https://clinicaltrials.gov/study/NCT02646397
  2. https://clinicaltrials.gov/study/NCT00051389
  3. https://clinicaltrials.gov/study/NCT01342614
  4. https://clinicaltrials.gov/study/NCT03073018
  5. https://clinicaltrials.gov/study/NCT00777972
  6. https://clinicaltrials.gov/study/NCT01014338